Drug Type Biosimilar, Colony-stimulating factors |
Synonyms- |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neutropenia | Phase 1 | - | 01 Jun 2021 |
Not Applicable | - | - | qbllnmmaod(zwycatgfij) = pogokchfxh ksrhkplpqq (bbmmyihojs ) | Positive | 25 May 2020 | ||
ztfbkkubgj(ccuithytpc) = zjhbizdict jsjreikqag (sfrarwccgf ) | |||||||
Not Applicable | - | - | (irkopnctyq) = Bone pain was similar with proposed biosimilar and reference pegfilgrastim, in studies of BC patients and HVs sysjzprycr (dqiupigebb ) | - | 22 Oct 2018 | ||